Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J, Spik G
Laboratoire de Chimie Biologique, Unité Mixte de Recherche du CNRS no. 111, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France.
Biochem J. 1995 Dec 15;312 ( Pt 3)(Pt 3):839-45. doi: 10.1042/bj3120839.
The ability of lactoferrin (Lf), an iron-binding glycoprotein that is also called lactotransferrin, to bind lipopolysaccharide (LPS) may be relevant to some of its biological properties. A knowledge of the LPS-binding site on Lf may help to explain the mechanism of its involvement in host defence. Our report reveals the presence of two Escherichia coli 055B5 LPS-binding sites on human Lf (hLf): a high-affinity binding site (Kd 3.6 +/- 1 nM) and a low-affinity binding site (Kd 390 +/- 20 nM). Bovine Lf (bLf), which shares about 70% amino acid sequence identity with hLf, exhibits the same behaviour towards LPS. Like hLf, bLf also contains a low- and a high-affinity LPS-binding site. The Kd value (4.5 +/- 2 nM) corresponding to the high-affinity binding site is similar to that obtained for hLf. Different LPS-binding sites for human serum transferrin have been suggested, as this protein, which is known to bind bacterial endotoxin, produced only 12% inhibition of hLf-LPS interaction. Binding and competitive binding experiments performed with the N-tryptic fragment (residues 4-283), the C-tryptic fragment (residues 284-692) and the N2-glycopeptide (residues 91-255) isolated from hLf have demonstrated that the high-affinity binding site is located in the N-terminal domain I of hLf, and the low-affinity binding site is present in the C-terminal lobe. The inhibition of hLf-LPS interaction by a synthetic octadecapeptide corresponding to residues 20-37 of hLf and lactoferricin B (residues 17-41), a proteolytic fragment from bLf, revealed the importance of the 28-34 loop region of hLf and the homologous region of bLf for LPS binding. Direct evidence that this amino acid sequence is involved in the high-affinity binding to LPS was demonstrated by assays carried out with EGS-loop hLf, a recombinant hLf mutated at residues 28-34.
乳铁蛋白(Lf)是一种铁结合糖蛋白,也被称为乳运铁蛋白,其结合脂多糖(LPS)的能力可能与其某些生物学特性相关。了解Lf上的LPS结合位点可能有助于解释其参与宿主防御的机制。我们的报告揭示了人乳铁蛋白(hLf)上存在两个大肠杆菌055B5 LPS结合位点:一个高亲和力结合位点(Kd 3.6±1 nM)和一个低亲和力结合位点(Kd 390±20 nM)。与hLf氨基酸序列同一性约为70%的牛乳铁蛋白(bLf)对LPS表现出相同的行为。与hLf一样,bLf也含有一个低亲和力和一个高亲和力LPS结合位点。对应于高亲和力结合位点的Kd值(4.5±2 nM)与hLf的相似。有人提出人血清转铁蛋白存在不同的LPS结合位点,因为这种已知能结合细菌内毒素的蛋白质仅对hLf-LPS相互作用产生12%的抑制。用从hLf分离的N-胰蛋白酶片段(第4 - 283位氨基酸残基)、C-胰蛋白酶片段(第284 - 692位氨基酸残基)和N2-糖肽(第91 - 255位氨基酸残基)进行的结合和竞争性结合实验表明,高亲和力结合位点位于hLf的N端结构域I,低亲和力结合位点存在于C端叶。对应于hLf第20 - 37位氨基酸残基的合成十八肽和乳铁蛋白B(第17 - 41位氨基酸残基,bLf的一个蛋白水解片段)对hLf-LPS相互作用的抑制作用揭示了hLf的28 - 34环区域和bLf的同源区域对LPS结合的重要性。用EGS-loop hLf(一种在第28 - 34位氨基酸残基处发生突变的重组hLf)进行的实验证明了该氨基酸序列参与与LPS的高亲和力结合的直接证据。